首页> 外文期刊>Leukemia and lymphoma >Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg?
【24h】

Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg?

机译:霍奇金淋巴瘤和白介素10:我们应该从冰山一角走下去吗?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hodgkin lymphoma (HL) is a malignant lympho-proliferation most commonly affecting young adults. Although the disease was first described more than 150 years ago, unraveling the pathogenesis and cellular nature of HL has been painstakingly slow . Two findings, in particular, make HL a unique malignant hematopoietic disease: first, the malignant mononucleated Hodgkin- and the multinucleated Reed-Sternberg (HRS) cells represent only a small fraction of cells in the affected lymph nodes and are embedded in an infiltrate of reactive hematopoietic cells .
机译:霍奇金淋巴瘤(HL)是最常影响年轻人的恶性淋巴增生。尽管这种疾病是在150多年前首次被描述的,但揭开HL的发病机理和细胞特性的努力却一直十分缓慢。特别是有两个发现,使HL成为一种独特的恶性造血系统疾病:首先,恶性单核霍奇金细胞和多核Reed-Sternberg(HRS)细胞仅占受影响淋巴结中的一小部分,并被包埋在反应性造血细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号